Etodolac Capsules
»Etodolac Capsules contain not less than 90.0percent and not more than 110.0percent of the labeled amount of etodolac (C17H21NO3).
Packaging and storage— Preserve in tight containers,and store at controlled room temperature.
Identification— The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that in the chromatogram of the Standard preparation,as obtained in the Assay.
Dissolution á711ñ
Medium: pH6.8phosphate buffer (see Buffer Solutions in the section Reagents,Indicators,and Solutions);1000mL.
Apparatus 1: 100rpm.
Time: 30minutes.
Procedure— Determine the amount of C17H21NO3dissolved by employing UVabsorption at the wavelength of maximum absorbance at about 274nm on filtered portions of the solution under test,suitably diluted with Dissolution Medium,if necessary,in comparison with a Standard solution having a known concentration of USP Etodolac RSin the same Medium.
Tolerances— Not less than 75%(Q)of the labeled amount of C17H21NO3is dissolved in 30minutes.
Uniformity of dosage units á905ñ: meet the requirements.
Assay—
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile,water,and phosphoric acid (500:500:0.25).Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Standard preparation— Dissolve an accurately weighed quantity of USP Etodolac RSin Mobile phaseto obtain a solution having a known concentration of about 0.2mg per mL.Prepare this solution fresh daily.
System suitability solution— Dissolve suitable quantities of USP Etodolac Related Compound A RSand USP Etodolac RSin Mobile phaseto obtain a solution containing about 0.01mg of etodolac related compound Aand 0.2mg of etodolac per mL.
Assay preparation— Weigh not fewer than 20Capsules,and transfer the contents as completely as possible to a suitable container.Remove any residual powder from the empty capsules with the aid of a current of air,and weigh the capsule shells,determining the weight of the contents by difference.Mix the contents of the Capsules,and transfer an accurately weighed portion of the powder,equivalent to about 1000mg of etodolac,to a 500-mLvolumetric flask,add 300mLof Mobile phase,shake for 15minutes,sonicate for 5minutes,cool,dilute with Mobile phaseto volume,and mix.Allow to settle for 10minutes.Pipet 10.0mLof the solution to a 100-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.Pass the solution through a filter having a 0.45-µm or finer porosity,prior to use.
Chromatographic system (see Chromatography á621ñ)— The liquid chromatograph is equipped with a 274-nm detector and a 4.6-mm ×25-cm column that contains packing L1.The flow rate is about 1.5mLper minute.Chromatograph the System suitability solution,and record the peak responses as directed for Procedure:the relative retention times are about 0.8for etodolac related compound Aand 1.0for etodolac;the resolution,R,between etodolac related compound Aand etodolac is not less than 2;the tailing factor is not more than 2;and the relative standard deviation for replicate injections is not more than 2%.
Procedure— Separately inject equal volumes (about 10µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of etodolac (C17H21NO3)in the portion of Capsule contents taken by the formula:
5000C(rU/rS),
in which Cis the concentration,in mg per mL,of USP Etodolac RSin the Standard preparation;and rUand rSare the etodolac peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Clydewyn M.Anthony,Ph.D.,Scientist
Expert Committee:(PA2)Pharmaceutical Analysis 2
USP28–NF23Page 800
Pharmacopeial Forum:Volume No.27(2)Page 2143
Phone Number:1-301-816-8139